U1035 INSERM

Sarah LESJEAN

Engineer Assistant — In charge of scientific mediation, communication and cultural projects.,
sarah.lesjean@inserm.fr

BIOSKETCH

PUBMED LINKEDIN

PATENTS

• Use of Glypican-3-targeting microRNAs for treating liver cancer. EP 15 3061072 07/07/2015 European patent UNIVERSITE DE BORDEAUX-INSERM Cartier, F., Lesjean, S., Sagliocco, F., and Grosset, C.
• Use of catenin-beta 1-targeting microRNAs for treating liver cancer. EP 15 3061130 2015 European patent UNIVERSITE DE BORDEAUX-INSERM-UNIVERSITE PARIS SUD - PARIS XI Indersie E., Lesjean S., Sagliocco F., Buenda M.-A., and Grosset, C.

Back to organigramme